Global Influenza Drugs Market Size study & Forecast, by Drug Type (Ribavirin, Oseltamivir, Relenza (Zanamivir), Peramivir, Influenza Vaccines), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) and Regional Analysis, 2023-2030
Global Influenza Drugs Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Influenza is a common viral infection that, if not carefully and rapidly treated, can be deadly. It affects the nose, throat, and lungs badly and is an infectious respiratory infection. The best way to prevent the flu, which is brought on by influenza viruses, is to be vaccinated annually. Runny nose, exhaustion, aches in the muscles, headaches, fever, and congestion are the most typical influenza symptoms. The key factors driving the market growth is increasing incidence and prevalence of influenza, rising healthcare expenditure worldwide, and increasing awareness and concern for public health that anticipated to support the market growth during forecast period 2023-2030.
Moreover, the increasing prevalence of influenza can have several implications that may contribute to the growth of the Influenza Drugs Market. As the number of influenza cases rises, there anticipated to be an increased demand for medications to alleviate symptoms and reduce the severity of the illness. This increased demand can drive pharmaceutical companies to develop and market new and more effective influenza drugs. According to a World Health Organisation study performed from January 24 to February 6, 2022, around 12,368 persons tested positive with influenza viruses. Of them, 8,423 (68.1%) were diagnosed with influenza A and 3,945 (31.9%) with influenza B. Furthermore, 171 (6.4%) were infected with influenza A (H1N1), whereas 2,483 (93.6%) were infected with influenza A (H3N2). Additionally, rise in R&D investments for discovery of new drugs is anticipated to create the lucrative opportunity for the market during forecast period. However, the high cost of drug development, and side effects associated with antiviral therapy stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Influenza Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising high incidence of influenza, increasing awareness, advancements in treatment, and supportive government initiatives. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing prevalence of influenza, growing awareness and healthcare infrastructure, rising government initiatives, and strong pharmaceutical industry presence.
Major market player included in this report are:
FACCUSA Laboratories Inc
Lonza Group Ltd
Bristol-Myers Squibb
Pfizer Inc.
GlaxoSmithKline plc
Novo Nordisk A/S
Sanofi
Cipla Limited
Bayer AG
Banting Medical Inc.
Recent Developments in the Market:
In November 2020, Shionogi & Co., Ltd. announced that its Licence Partner F. Hoffmann-La Roche Ltd., which holds worldwide rights to Xofluza® except in Japan and Taiwan, has received FDA approval for a supplemental New Drug Application (sNDA) for Xofluza (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone who has influenza (known as post-exposure prophylaxis). The first single-dose influenza drug licenced for post-exposure prophylaxis is Xofluza.
Global Influenza Drugs Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Drug Type, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Ribavirin
Oseltamivir
Relenza (Zanamivir)
Peramivir
Influenza Vaccines
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Channel
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Moreover, the increasing prevalence of influenza can have several implications that may contribute to the growth of the Influenza Drugs Market. As the number of influenza cases rises, there anticipated to be an increased demand for medications to alleviate symptoms and reduce the severity of the illness. This increased demand can drive pharmaceutical companies to develop and market new and more effective influenza drugs. According to a World Health Organisation study performed from January 24 to February 6, 2022, around 12,368 persons tested positive with influenza viruses. Of them, 8,423 (68.1%) were diagnosed with influenza A and 3,945 (31.9%) with influenza B. Furthermore, 171 (6.4%) were infected with influenza A (H1N1), whereas 2,483 (93.6%) were infected with influenza A (H3N2). Additionally, rise in R&D investments for discovery of new drugs is anticipated to create the lucrative opportunity for the market during forecast period. However, the high cost of drug development, and side effects associated with antiviral therapy stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Influenza Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising high incidence of influenza, increasing awareness, advancements in treatment, and supportive government initiatives. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing prevalence of influenza, growing awareness and healthcare infrastructure, rising government initiatives, and strong pharmaceutical industry presence.
Major market player included in this report are:
FACCUSA Laboratories Inc
Lonza Group Ltd
Bristol-Myers Squibb
Pfizer Inc.
GlaxoSmithKline plc
Novo Nordisk A/S
Sanofi
Cipla Limited
Bayer AG
Banting Medical Inc.
Recent Developments in the Market:
In November 2020, Shionogi & Co., Ltd. announced that its Licence Partner F. Hoffmann-La Roche Ltd., which holds worldwide rights to Xofluza® except in Japan and Taiwan, has received FDA approval for a supplemental New Drug Application (sNDA) for Xofluza (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone who has influenza (known as post-exposure prophylaxis). The first single-dose influenza drug licenced for post-exposure prophylaxis is Xofluza.
Global Influenza Drugs Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Drug Type, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Type:
Ribavirin
Oseltamivir
Relenza (Zanamivir)
Peramivir
Influenza Vaccines
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Channel
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Influenza Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Influenza Drugs Market, by Drug Type, 2020-2030 (USD Billion)
1.2.3. Influenza Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INFLUENZA DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INFLUENZA DRUGS MARKET DYNAMICS
3.1. Influenza Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence and prevalence of influenza
3.1.1.2. Rising healthcare expenditure worldwide
3.1.1.3. Increasing awareness and concern for public health
3.1.2. Market Challenges
3.1.2.1. High cost of drug development
3.1.2.2. Side effects associated with antiviral therapy
3.1.3. Market Opportunities
3.1.3.1. Rise in R&D investments for discovery of new drugs
CHAPTER 4. GLOBAL INFLUENZA DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INFLUENZA DRUGS MARKET, BY DRUG TYPE
5.1. Market Snapshot
5.2. Global Influenza Drugs Market by Drug Type, Performance - Potential Analysis
5.3. Global Influenza Drugs Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
5.4. Influenza Drugs Market, Sub Segment Analysis
5.4.1. Ribavirin
5.4.2. Oseltamivir
5.4.3. Relenza (Zanamivir)
5.4.4. Peramivir
5.4.5. Influenza Vaccines
CHAPTER 6. GLOBAL INFLUENZA DRUGS MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Influenza Drugs Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Influenza Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Influenza Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Channel
CHAPTER 7. GLOBAL INFLUENZA DRUGS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Influenza Drugs Market, Regional Market Snapshot
7.4. North America Influenza Drugs Market
7.4.1. U.S. Influenza Drugs Market
7.4.1.1. Drug Type breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Influenza Drugs Market
7.5. Europe Influenza Drugs Market Snapshot
7.5.1. U.K. Influenza Drugs Market
7.5.2. Germany Influenza Drugs Market
7.5.3. France Influenza Drugs Market
7.5.4. Spain Influenza Drugs Market
7.5.5. Italy Influenza Drugs Market
7.5.6. Rest of Europe Influenza Drugs Market
7.6. Asia-Pacific Influenza Drugs Market Snapshot
7.6.1. China Influenza Drugs Market
7.6.2. India Influenza Drugs Market
7.6.3. Japan Influenza Drugs Market
7.6.4. Australia Influenza Drugs Market
7.6.5. South Korea Influenza Drugs Market
7.6.6. Rest of Asia Pacific Influenza Drugs Market
7.7. Latin America Influenza Drugs Market Snapshot
7.7.1. Brazil Influenza Drugs Market
7.7.2. Mexico Influenza Drugs Market
7.8. Middle East & Africa Influenza Drugs Market
7.8.1. Saudi Arabia Influenza Drugs Market
7.8.2. South Africa Influenza Drugs Market
7.8.3. Rest of Middle East & Africa Influenza Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. FACCUSA Laboratories Inc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Lonza Group Ltd
8.3.3. Bristol-Myers Squibb
8.3.4. Pfizer Inc.
8.3.5. GlaxoSmithKline plc
8.3.6. Novo Nordisk A/S
8.3.7. Sanofi
8.3.8. Cipla Limited
8.3.9. Bayer AG
8.3.10. Banting Medical Inc.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
12. List ofTables
TABLE 1. Global Influenza Drugs Market, report scope
TABLE 2. Global Influenza Drugs Market estimates & forecasts by region 2020-2030 (USD Billion)
TABLE 3. Global Influenza Drugs Market estimates & forecasts by Drug Type 2020-2030 (USD Billion)
TABLE 4. Global Influenza Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. 12. List ofsecondary sources, used in the study of global Influenza Drugs Market
TABLE 70. 12. List ofprimary sources, used in the study of global Influenza Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
12. List oftables and figures and dummy in nature, final lists may vary in the final deliverable
12. List offigures
FIG 1. Global Influenza Drugs Market, research methodology
FIG 2. Global Influenza Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Influenza Drugs Market, key trends 2022
FIG 5. Global Influenza Drugs Market, growth prospects 2023-2030
FIG 6. Global Influenza Drugs Market, porters 5 force model
FIG 7. Global Influenza Drugs Market, pest analysis
FIG 8. Global Influenza Drugs Market, value chain analysis
FIG 9. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Influenza Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Influenza Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Influenza Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Influenza Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Influenza Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Influenza Drugs Market 2020 & 2030 (USD Billion)
12. List oftables and figures and dummy in nature, final lists may vary in the final deliverable
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Influenza Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Influenza Drugs Market, by Drug Type, 2020-2030 (USD Billion)
1.2.3. Influenza Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INFLUENZA DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INFLUENZA DRUGS MARKET DYNAMICS
3.1. Influenza Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence and prevalence of influenza
3.1.1.2. Rising healthcare expenditure worldwide
3.1.1.3. Increasing awareness and concern for public health
3.1.2. Market Challenges
3.1.2.1. High cost of drug development
3.1.2.2. Side effects associated with antiviral therapy
3.1.3. Market Opportunities
3.1.3.1. Rise in R&D investments for discovery of new drugs
CHAPTER 4. GLOBAL INFLUENZA DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL INFLUENZA DRUGS MARKET, BY DRUG TYPE
5.1. Market Snapshot
5.2. Global Influenza Drugs Market by Drug Type, Performance - Potential Analysis
5.3. Global Influenza Drugs Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
5.4. Influenza Drugs Market, Sub Segment Analysis
5.4.1. Ribavirin
5.4.2. Oseltamivir
5.4.3. Relenza (Zanamivir)
5.4.4. Peramivir
5.4.5. Influenza Vaccines
CHAPTER 6. GLOBAL INFLUENZA DRUGS MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Influenza Drugs Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Influenza Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Influenza Drugs Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Channel
CHAPTER 7. GLOBAL INFLUENZA DRUGS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Influenza Drugs Market, Regional Market Snapshot
7.4. North America Influenza Drugs Market
7.4.1. U.S. Influenza Drugs Market
7.4.1.1. Drug Type breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Influenza Drugs Market
7.5. Europe Influenza Drugs Market Snapshot
7.5.1. U.K. Influenza Drugs Market
7.5.2. Germany Influenza Drugs Market
7.5.3. France Influenza Drugs Market
7.5.4. Spain Influenza Drugs Market
7.5.5. Italy Influenza Drugs Market
7.5.6. Rest of Europe Influenza Drugs Market
7.6. Asia-Pacific Influenza Drugs Market Snapshot
7.6.1. China Influenza Drugs Market
7.6.2. India Influenza Drugs Market
7.6.3. Japan Influenza Drugs Market
7.6.4. Australia Influenza Drugs Market
7.6.5. South Korea Influenza Drugs Market
7.6.6. Rest of Asia Pacific Influenza Drugs Market
7.7. Latin America Influenza Drugs Market Snapshot
7.7.1. Brazil Influenza Drugs Market
7.7.2. Mexico Influenza Drugs Market
7.8. Middle East & Africa Influenza Drugs Market
7.8.1. Saudi Arabia Influenza Drugs Market
7.8.2. South Africa Influenza Drugs Market
7.8.3. Rest of Middle East & Africa Influenza Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. FACCUSA Laboratories Inc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Lonza Group Ltd
8.3.3. Bristol-Myers Squibb
8.3.4. Pfizer Inc.
8.3.5. GlaxoSmithKline plc
8.3.6. Novo Nordisk A/S
8.3.7. Sanofi
8.3.8. Cipla Limited
8.3.9. Bayer AG
8.3.10. Banting Medical Inc.
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
12. List ofTables
TABLE 1. Global Influenza Drugs Market, report scope
TABLE 2. Global Influenza Drugs Market estimates & forecasts by region 2020-2030 (USD Billion)
TABLE 3. Global Influenza Drugs Market estimates & forecasts by Drug Type 2020-2030 (USD Billion)
TABLE 4. Global Influenza Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Influenza Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Influenza Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Influenza Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Influenza Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. 12. List ofsecondary sources, used in the study of global Influenza Drugs Market
TABLE 70. 12. List ofprimary sources, used in the study of global Influenza Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
12. List oftables and figures and dummy in nature, final lists may vary in the final deliverable
12. List offigures
FIG 1. Global Influenza Drugs Market, research methodology
FIG 2. Global Influenza Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Influenza Drugs Market, key trends 2022
FIG 5. Global Influenza Drugs Market, growth prospects 2023-2030
FIG 6. Global Influenza Drugs Market, porters 5 force model
FIG 7. Global Influenza Drugs Market, pest analysis
FIG 8. Global Influenza Drugs Market, value chain analysis
FIG 9. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Influenza Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Influenza Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Influenza Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Influenza Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Influenza Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Influenza Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Influenza Drugs Market 2020 & 2030 (USD Billion)
12. List oftables and figures and dummy in nature, final lists may vary in the final deliverable
